Progress in Developing Fibroblast Cell Therapies with FibroBiologics CEO, Pete O'Heeron

from Rx for Biotech · host Podcast Host Chris Leidli

FibroBiologics is the leading biotech company focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. In this podcast episode, the Founder and CEO, Pete O'Heeron discusses the promise of fibroblast cell therapy to treat diseases such as multiple sclerosis, degenerative disk disease and more.

Episode metadata supplied by the publisher feed · Published May 2, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Progress in Developing Fibroblast Cell Therapies with FibroBiologics CEO, Pete O'Heeron

0:00 18:03

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 18 minutes long.

When was this Rx for Biotech episode published?

This episode was published on May 2, 2023.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!